Cargando…
Rare Causes of Isolated and Progressive Splenic Lesions: Challenges in Differential Diagnosis, Evaluation, and Treatment of Primary Splenic Lymphomas
The spleen is among the most common extranodal sites for Hodgkin and non-Hodgkin lymphomas (NHLs); however, among lymphomas arising from the spleen, primary splenic lymphomas (PSLs) are rare. The group of PSLs includes primary splenic diffuse large B-cell lymphoma (PS-DLBCL), splenic red pulp small...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288794/ https://www.ncbi.nlm.nih.gov/pubmed/32565679 http://dx.doi.org/10.1177/1179545X20926188 |
_version_ | 1783545338811908096 |
---|---|
author | Sinit, Ryan B Dorer, Russell K Flores, John Paul Aboulafia, David M |
author_facet | Sinit, Ryan B Dorer, Russell K Flores, John Paul Aboulafia, David M |
author_sort | Sinit, Ryan B |
collection | PubMed |
description | The spleen is among the most common extranodal sites for Hodgkin and non-Hodgkin lymphomas (NHLs); however, among lymphomas arising from the spleen, primary splenic lymphomas (PSLs) are rare. The group of PSLs includes primary splenic diffuse large B-cell lymphoma (PS-DLBCL), splenic red pulp small B-cell lymphoma, splenic marginal zone lymphoma (SMZL), and a splenic hairy cell leukemia variant. Delineating between the PSL variants can be challenging, especially as fine-needle aspirate and core needle biopsy of the spleen are not routinely offered at most medical centers. Herein, we describe the clinical course of 2 representative patients who presented with non-specific gastrointestinal symptoms, the first who was diagnosed with PS-DLBCL and the second who was diagnosed with SMZL. We review and contrast the clinical presentations, imaging techniques, and laboratory findings of these discrete lymphoma variants and offer strategies on how to delineate between these varied splenic processes. We also examine the use of splenectomy and splenic needle biopsy as diagnostics and, in the case of splenectomy, a therapeutic tool. Finally, we also briefly review treatment options for these varied lymphoma sub-types while acknowledging that randomized trials to guide best practices for PSLs are lacking. |
format | Online Article Text |
id | pubmed-7288794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-72887942020-06-19 Rare Causes of Isolated and Progressive Splenic Lesions: Challenges in Differential Diagnosis, Evaluation, and Treatment of Primary Splenic Lymphomas Sinit, Ryan B Dorer, Russell K Flores, John Paul Aboulafia, David M Clin Med Insights Blood Disord Case Report The spleen is among the most common extranodal sites for Hodgkin and non-Hodgkin lymphomas (NHLs); however, among lymphomas arising from the spleen, primary splenic lymphomas (PSLs) are rare. The group of PSLs includes primary splenic diffuse large B-cell lymphoma (PS-DLBCL), splenic red pulp small B-cell lymphoma, splenic marginal zone lymphoma (SMZL), and a splenic hairy cell leukemia variant. Delineating between the PSL variants can be challenging, especially as fine-needle aspirate and core needle biopsy of the spleen are not routinely offered at most medical centers. Herein, we describe the clinical course of 2 representative patients who presented with non-specific gastrointestinal symptoms, the first who was diagnosed with PS-DLBCL and the second who was diagnosed with SMZL. We review and contrast the clinical presentations, imaging techniques, and laboratory findings of these discrete lymphoma variants and offer strategies on how to delineate between these varied splenic processes. We also examine the use of splenectomy and splenic needle biopsy as diagnostics and, in the case of splenectomy, a therapeutic tool. Finally, we also briefly review treatment options for these varied lymphoma sub-types while acknowledging that randomized trials to guide best practices for PSLs are lacking. SAGE Publications 2020-06-10 /pmc/articles/PMC7288794/ /pubmed/32565679 http://dx.doi.org/10.1177/1179545X20926188 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Sinit, Ryan B Dorer, Russell K Flores, John Paul Aboulafia, David M Rare Causes of Isolated and Progressive Splenic Lesions: Challenges in Differential Diagnosis, Evaluation, and Treatment of Primary Splenic Lymphomas |
title | Rare Causes of Isolated and Progressive Splenic Lesions: Challenges
in Differential Diagnosis, Evaluation, and Treatment of Primary Splenic
Lymphomas |
title_full | Rare Causes of Isolated and Progressive Splenic Lesions: Challenges
in Differential Diagnosis, Evaluation, and Treatment of Primary Splenic
Lymphomas |
title_fullStr | Rare Causes of Isolated and Progressive Splenic Lesions: Challenges
in Differential Diagnosis, Evaluation, and Treatment of Primary Splenic
Lymphomas |
title_full_unstemmed | Rare Causes of Isolated and Progressive Splenic Lesions: Challenges
in Differential Diagnosis, Evaluation, and Treatment of Primary Splenic
Lymphomas |
title_short | Rare Causes of Isolated and Progressive Splenic Lesions: Challenges
in Differential Diagnosis, Evaluation, and Treatment of Primary Splenic
Lymphomas |
title_sort | rare causes of isolated and progressive splenic lesions: challenges
in differential diagnosis, evaluation, and treatment of primary splenic
lymphomas |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288794/ https://www.ncbi.nlm.nih.gov/pubmed/32565679 http://dx.doi.org/10.1177/1179545X20926188 |
work_keys_str_mv | AT sinitryanb rarecausesofisolatedandprogressivespleniclesionschallengesindifferentialdiagnosisevaluationandtreatmentofprimaryspleniclymphomas AT dorerrussellk rarecausesofisolatedandprogressivespleniclesionschallengesindifferentialdiagnosisevaluationandtreatmentofprimaryspleniclymphomas AT floresjohnpaul rarecausesofisolatedandprogressivespleniclesionschallengesindifferentialdiagnosisevaluationandtreatmentofprimaryspleniclymphomas AT aboulafiadavidm rarecausesofisolatedandprogressivespleniclesionschallengesindifferentialdiagnosisevaluationandtreatmentofprimaryspleniclymphomas |